Neuroinflammation and the generation of neuropathic pain

被引:447
|
作者
Ellis, A. [1 ]
Bennett, D. L. H. [2 ]
机构
[1] Kings Coll London, London SE1 1UL, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
immune response; pain; neuropathic; DORSAL-ROOT GANGLION; PERIPHERAL-NERVE INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PRO-INFLAMMATORY CYTOKINES; SPINAL-CORD MICROGLIA; NECROSIS-FACTOR-ALPHA; CATHEPSIN-S; RAT MODEL; IMMUNE-SYSTEM; UP-REGULATION;
D O I
10.1093/bja/aet128
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Inflammation is the process by which an organism responds to tissue injury involving both immune cell recruitment and mediator release. Diverse causes of neuropathic pain are associated with excessive inflammation in both the peripheral and central nervous system which may contribute to the initiation and maintenance of persistent pain. Chemical mediators, such as cytokines, chemokines, and lipid mediators, released during an inflammatory response have the undesired effect of sensitizing and stimulating nociceptors, their central synaptic targets or both. These changes can promote long-term maladaptive plasticity resulting in persistent neuropathic pain. This review aims to provide an overview of inflammatory mechanisms at differing levels of the sensory neuroaxis with a focus on neuropathic pain. We will compare and contrast neuropathic pain states such as traumatic nerve injury which is associated with a vigorous inflammatory response and chemotherapy induced pain in which the inflammatory response is much more modest. Targeting excessive inflammation in neuropathic pain provides potential therapeutic opportunities and we will discuss some of the opportunities but also the clinical challenges in such an approach.
引用
收藏
页码:26 / 37
页数:12
相关论文
共 50 条
  • [21] Epigenetic Modifications Associated to Neuroinflammation and Neuropathic Pain After Neural Trauma
    Penas, Clara
    Navarro, Xavier
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [22] Immunotherapy targeting cytokines in neuropathic pain
    Hua, Susan
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [23] Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy
    Kalynovska, Nataliia
    Diallo, Mickael
    Sotakova-Kasparova, Dita
    Palecek, Jiri
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (14) : 7949 - 7958
  • [24] Implication of system xc- in neuroinflammation during the onset and maintenance of neuropathic pain
    Beckers, Pauline
    Do Nascimento, Ines Belo
    Charlier, Mathilde
    Desmet, Nathalie
    Massie, Ann
    Hermans, Emmanuel
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [25] Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation
    Alexander, Jessica K.
    DeVries, A. Courtney
    Kigerl, Kristina A.
    Dahlman, Jason M.
    Popovich, Phillip G.
    BRAIN BEHAVIOR AND IMMUNITY, 2009, 23 (06) : 851 - 860
  • [26] The Epigenetics of Neuropathic Pain: A Systematic Update
    Petho, Gabor
    Kantas, Boglarka
    Horvath, Adam
    Pinter, Erika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [27] Neuropathic pain: mechanisms and their clinical implications
    Cohen, Steven P.
    Mao, Jianren
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [28] Biomarkers for microglia activation in neuropathic pain
    Widyadharma, Putu Eka
    Vania, Aurelia
    Barus, Jimmy F. A.
    Yudiyanta
    Purwata, Thomas Eko
    ANAESTHESIA PAIN & INTENSIVE CARE, 2020, 24 (01) : 87 - 93
  • [29] Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
    Martini, Alessandra Cadete
    Berta, Temugin
    Forner, Stefania
    Chen, Gang
    Bento, Allisson Freire
    Ji, Ru-Rong
    Rae, Giles Alexander
    JOURNAL OF NEUROINFLAMMATION, 2016, 13
  • [30] Opioids and Neuropathic Pain
    Smith, Howard S.
    PAIN PHYSICIAN, 2012, 15 (03) : ES93 - ES110